BTK Inhibitors in Treatment-Naive CLL

Source: Chronic Lymphocytic Leukemia: New Horizons With BTK Inhibitors
Download Slideset
Downloadable slides with expert analysis of the use of BTK inhibitors for patients with treatment-naive CLL.
Danielle Brander, MD
Format: Microsoft PowerPoint (.ppt)
File Size: 784 KB
Released: June 10, 2020

Acknowledgements

Provided by Clinical Care Options, LLC
Contact Info

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by an educational grant from
AstraZeneca

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings